Literature DB >> 2520662

Nicardipine, a new intravenous calcium antagonist: a review of its pharmacology, pharmacokinetics, and perioperative applications.

P Turlapaty1, R Vary, J A Kaplan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2520662     DOI： 10.1016/0888-6296(89)90120-8

Source DB:  PubMed          Journal:  J Cardiothorac Anesth        ISSN： 0888-6296


× No keyword cloud information.
  8 in total

1.  Hemodynamic effects of KRN2391 (potassium channel opener) in halothane-anesthetized dogs.

Authors:  Shohei Takeda; Yutaka Inada; Yoshiki Ozawa; Narue Nakamizo; Teruaki Tomaru
Journal:  J Anesth       Date:  1995-06       Impact factor: 2.078

2.  Nicardipine reduces the cardio-respiratory toxicity of intravenously administered bupivacaine in rats.

Authors:  F Matsuda; W W Kinney; W Wright; J R Kambam
Journal:  Can J Anaesth       Date:  1990-11       Impact factor: 5.063

3.  Systemic vasomotor interaction between nicardipine and hypocapnic alkalosis in man.

Authors:  P Combes; B Fauvage
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

4.  Intravenous nicardipine in hypertensive children.

Authors:  J M Treluyer; P Hubert; P Jouvet; S Couderc; M Cloup
Journal:  Eur J Pediatr       Date:  1993-09       Impact factor: 3.183

5.  Intravenous nicardipine does not alter hepatic blood flow after orthotopic liver transplant.

Authors:  M Raucoules-Aimé; M Drici; B Goubaux; Y Labib; C Ichai; J Gugenheim; D Grimaud
Journal:  Intensive Care Med       Date:  1996-05       Impact factor: 17.440

6.  Combined effects of nicardipine and hypocapnic alkalosis on cerebral vasomotor activity and intracranial pressure in man.

Authors:  P Combes; M Durand
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

7.  Malignant hypertension: does this still exist?

Authors:  Magdalena Domek; Jakub Gumprecht; Gregory Y H Lip; Alena Shantsila
Journal:  J Hum Hypertens       Date:  2019-10-21       Impact factor: 3.012

Review 8.  Clinical review: the management of hypertensive crises.

Authors:  Joseph Varon; Paul E Marik
Journal:  Crit Care       Date:  2003-07-16       Impact factor: 9.097
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.